Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by the degeneration of motor neurons. Though many molecular and genetic causes are thought to serve as predisposing or disease propagating factors, the underlying pathogenesis of the disease is not known. Re...
Main Authors: | Syed I. Khalid, Leonel Ampie, Ryan Kelly, Shafeeq S. Ladha, Christopher Dardis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-09-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fneur.2017.00486/full |
Similar Items
-
Innate and adaptive immunity in amyotrophic lateral sclerosis: Evidence of complement activation
by: M. Sta, et al.
Published: (2011-06-01) -
Amyotrophic Lateral Sclerosis
Published: (2021) -
Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis
by: Savina Apolloni, et al.
Published: (2017-11-01) -
Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
by: Reka P. Toth, et al.
Published: (2018-05-01) -
Investigation of some variations of superoxide dismutase gene family in Turkish sporadic amyotrophic lateral sclerosis patients
by: Melda Büyüköz, et al.
Published: (2021-09-01)